Arbutus Biopharma Corp. (ABUS)
Arbutus Biopharma Market Cap : 815.04M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 815.04M |
| November 12, 2026 | 803.08M |
| November 11, 2026 | 773.19M |
| November 10, 2026 | 761.23M |
| November 09, 2026 | 741.31M |
| November 06, 2026 | 728.35M |
| November 05, 2026 | 731.34M |
| November 04, 2026 | 802.39M |
| November 03, 2026 | 766.82M |
| November 02, 2026 | 790.54M |
| October 30, 2026 | 832.04M |
| October 29, 2026 | 845.87M |
| October 28, 2026 | 853.78M |
| October 27, 2026 | 847.85M |
| October 26, 2026 | 830.06M |
| October 23, 2026 | 830.06M |
| October 22, 2026 | 832.04M |
| October 21, 2026 | 826.11M |
| October 20, 2026 | 855.76M |
| October 19, 2026 | 835.99M |
| October 16, 2026 | 834.02M |
| October 15, 2026 | 847.85M |
| October 14, 2026 | 828.09M |
| October 13, 2026 | 812.28M |
| October 12, 2026 | 820.18M |
| Date | Value |
|---|---|
| October 09, 2026 | 834.02M |
| October 08, 2026 | 826.11M |
| October 07, 2026 | 847.85M |
| October 06, 2026 | 885.40M |
| October 05, 2026 | 922.95M |
| October 02, 2026 | 879.47M |
| October 01, 2026 | 901.21M |
| September 30, 2026 | 944.69M |
| September 29, 2026 | 926.90M |
| September 28, 2026 | 960.50M |
| September 25, 2026 | 958.53M |
| September 24, 2026 | 964.45M |
| September 23, 2026 | 958.53M |
| September 22, 2026 | 990.15M |
| September 21, 2026 | 988.17M |
| September 18, 2026 | 990.15M |
| September 17, 2026 | 1.002B |
| September 16, 2026 | 998.05M |
| September 15, 2026 | 1.000B |
| September 14, 2026 | 1.014B |
| September 11, 2026 | 1.012B |
| September 10, 2026 | 1.012B |
| September 09, 2026 | 1.022B |
| September 08, 2026 | 1.024B |
| September 04, 2026 | 1.018B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gossamer Bio, Inc. | 67.10M |
| ACADIA Pharmaceuticals, Inc. | 3.240B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 179.48M |
| Savara, Inc. | 953.69M |
Market Cap Related Metrics
| PE Ratio | 3.652 |
| PS Ratio | 4.422 |
| Price to Book Value | 9.505 |
| Price to Free Cash Flow | 3.663 |
| Price | 4.09 |
| Earnings Yield | 27.38% |
| Operating PE Ratio | 5.517 |
| Normalized PE Ratio | 3.673 |